Bellerophon Therapeutics, Inc. Retained Earnings
Bellerophon Therapeutics, Inc. had Retained Earnings of -$256.31 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-14
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$256.31M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$254.39M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$249.26M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$252.08M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-09-30 | -$256.31M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$254.39M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$249.26M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$252.08M 10-Q · filed 2023-11-14 |
| 2022-09-30 | -$247.06M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$241.99M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$237.89M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$232.25M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$227.97M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$223.34M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$219.95M 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$214.49M 10-K · filed 2022-03-31 |
| 2020-09-30 | -$206.49M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$198.55M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$194.73M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$189.76M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$185.68M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$181.40M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$177.29M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$176.50M 10-K · filed 2020-04-06 |
| 2018-09-30 | -$175.58M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$186.69M 10-Q · filed 2018-08-01 |
| 2018-03-31 | -$175.21M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$179.31M 10-K · filed 2019-03-14 |
| 2017-09-30 | -$155.15M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$147.56M 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$143.63M 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$124.49M 10-K · filed 2018-03-15 |
| 2016-09-30 | -$117.07M 10-Q · filed 2016-11-08 |
| 2016-06-30 | -$112.87M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$107.74M 10-Q · filed 2016-05-10 |
| 2015-12-31 | -$100.68M 10-K · filed 2017-03-13 |
| 2015-09-30 | -$89.85M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$78.71M 10-Q · filed 2015-08-14 |
| 2015-03-31 | -$67.13M 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$54.22M 10-K · filed 2016-03-21 |